In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 14.59% ...

Piper Sandler analyst Scott Siefers maintained a Hold rating on Bank of America (BAC – Research Report) today and set a price target of $49.00.

Charles Schwab Corporation Common Stock (SCHW) stock saw a modest uptick, ending the day at $76.41 which represents a slight increase of $0.90 or 1.19% from the prior close of $75.51. The stock opened ...

Piper Sandler’s price objective ... from $16.00 to $18.00 and gave the company a “neutral” rating in a research report on Monday, October 21st. Barclays boosted their price target on shares ...

Ecolab (NYSE:ECL – Free Report) had its target price reduced by Piper ... basic materials company’s stock. Several other equities analysts have also issued reports on ECL. Barclays lifted ...

Piper Sandler adjusted its outlook on Charles Schwab Corp (BVMF:SCHW34). (NYSE: SCHW) shares, increasing the price target to $78 from $70 while maintaining a Neutral rating. The decision followed ...

US stocks ended higher on Friday, driven by gains in big tech and chip companies, reported Xinhua. The Dow Jones Industrial ...